Your browser doesn't support javascript.
loading
Ultrasonographic assessment of cardiac function and disease severity in coronary heart disease.
Zhang, Jing-Fang; Du, Yin-Hui; Hu, Hai-Yan; Han, Xiu-Qing.
Afiliação
  • Zhang JF; Ultrasonic Department, The Second Affiliated Hospital of Xi'an Medical College, Xi'an 710038, Shaanxi Province, China.
  • Du YH; Ultrasonic Department, Xi'an Fifth Hospital Shanxi Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Xi'an 710082, Shaanxi Province, China. xiaozhangok9999@163.com.
  • Hu HY; Ultrasonic Department, The Second Affiliated Hospital of Xi'an Medical College, Xi'an 710038, Shaanxi Province, China.
  • Han XQ; Ultrasonic Department, The Second Affiliated Hospital of Xi'an Medical College, Xi'an 710038, Shaanxi Province, China.
World J Clin Cases ; 9(28): 8366-8373, 2021 Oct 06.
Article em En | MEDLINE | ID: mdl-34754846
ABSTRACT

BACKGROUND:

Coronary heart disease (CHD) causes many adverse cardiovascular events and poses a threat to the patient's health and quality of life.

AIM:

To evaluate ultrasonography for evaluation of cardiac function and lesion degree in patients with CHD.

METHODS:

A total of 106 patients with CHD (study group) and 106 healthy individuals (control group) in our hospital from March 2019 to September 2020 were selected for this study. All subjects were examined by ultrasound, and the mitral orifice's early-to-late diastolic blood flow velocity ratio (E/A), left ventricular end-diastolic volume (LVDd), and left atrial diameter (LAD) were measured. Values were compared between the study group and healthy group, and the correlation between the ultrasonic parameters of patients with different cardiac function grades and the degree of CHD were assessed. In addition, the ultrasonic parameters of patients with different prognoses were compared after a follow-up for 6 mo.

RESULTS:

E/A (1.46 ± 0.34) of the study group was smaller than that of the control group (1.88 ± 0.44), while LVDd (58.24 ± 5.05 mm) and LAD (43.31 ± 4.38 mm) were larger (48.15 ± 3.93 and 34.94 ± 2.81, respectively; P < 0.05). E/A for patients with grade III disease (1.41 ± 0.43) was smaller and their LVDd (60.04 ± 4.21 mm) and LA (44.16 ± 2.79 mm) were larger than those in patients with grade II disease (1.71 ± 0.48, 52.18 ± 3.67 mm, and 39.68 ± 2.37, respectively; P < 0.05). Patients with grade IV disease had smaller E/A (1.08 ± 0.39) and larger LVDd (66.81 ± 5.39 mm) and LAD (48.81 ± 3.95 mm) than patients with grade II and III disease (P < 0.05). In patients with moderate disease, E/A (1.44 ± 0.41) was smaller and LVDd (59.95 ± 4.14 mm) and LAD (45.15 ± 2.97 mm) were larger than in patients with mild disease (1.69 ± 0.50, 51.97 ± 3.88 and 38.81 ± 2.56 mm, respectively; P < 0.05). In patients with severe disease, E/A (1.13 ± 0.36) was smaller and LVDd (67.70 ± 6.11 mm) and LAD (49.09 ± 4.05 mm) were larger than in patients with moderate disease (P < 0.05). E/A was negatively correlated with cardiac function classification and disease severity, while LVDd and LAD were positively correlated with cardiac function classification and disease severity (P < 0.05). E/A (1.83 ± 0.51) for patients with good prognosis was higher than that for those with poor prognosis (1.39 ± 0.32), while LVDd (49.60 ± 4.39 mm) and LAD (36.13 ± 3.05 mm) were lower (P < 0.05).

CONCLUSION:

The ultrasonic parameters of patients with CHD are abnormal, and differ significantly in patients with different cardiac function grades, lesion degree, and prognosis.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article